S&P 500   5,066.40 (-0.06%)
DOW   38,902.45 (-0.43%)
QQQ   437.27 (+0.16%)
AAPL   180.90 (-0.14%)
MSFT   405.73 (-0.44%)
META   483.21 (+0.31%)
GOOGL   137.83 (+0.19%)
AMZN   174.20 (-0.30%)
TSLA   201.91 (+1.26%)
NVDA   791.66 (+0.09%)
NIO   5.80 (+2.65%)
AMD   177.87 (+1.06%)
BABA   77.65 (+1.49%)
T   16.61 (+0.06%)
F   12.06 (+0.92%)
MU   91.65 (+2.45%)
CGC   3.57 (+2.88%)
GE   153.59 (-0.76%)
DIS   108.49 (+0.75%)
AMC   4.68 (+5.17%)
PFE   26.97 (-0.77%)
PYPL   59.96 (+1.06%)
XOM   104.14 (-0.11%)
S&P 500   5,066.40 (-0.06%)
DOW   38,902.45 (-0.43%)
QQQ   437.27 (+0.16%)
AAPL   180.90 (-0.14%)
MSFT   405.73 (-0.44%)
META   483.21 (+0.31%)
GOOGL   137.83 (+0.19%)
AMZN   174.20 (-0.30%)
TSLA   201.91 (+1.26%)
NVDA   791.66 (+0.09%)
NIO   5.80 (+2.65%)
AMD   177.87 (+1.06%)
BABA   77.65 (+1.49%)
T   16.61 (+0.06%)
F   12.06 (+0.92%)
MU   91.65 (+2.45%)
CGC   3.57 (+2.88%)
GE   153.59 (-0.76%)
DIS   108.49 (+0.75%)
AMC   4.68 (+5.17%)
PFE   26.97 (-0.77%)
PYPL   59.96 (+1.06%)
XOM   104.14 (-0.11%)
S&P 500   5,066.40 (-0.06%)
DOW   38,902.45 (-0.43%)
QQQ   437.27 (+0.16%)
AAPL   180.90 (-0.14%)
MSFT   405.73 (-0.44%)
META   483.21 (+0.31%)
GOOGL   137.83 (+0.19%)
AMZN   174.20 (-0.30%)
TSLA   201.91 (+1.26%)
NVDA   791.66 (+0.09%)
NIO   5.80 (+2.65%)
AMD   177.87 (+1.06%)
BABA   77.65 (+1.49%)
T   16.61 (+0.06%)
F   12.06 (+0.92%)
MU   91.65 (+2.45%)
CGC   3.57 (+2.88%)
GE   153.59 (-0.76%)
DIS   108.49 (+0.75%)
AMC   4.68 (+5.17%)
PFE   26.97 (-0.77%)
PYPL   59.96 (+1.06%)
XOM   104.14 (-0.11%)
S&P 500   5,066.40 (-0.06%)
DOW   38,902.45 (-0.43%)
QQQ   437.27 (+0.16%)
AAPL   180.90 (-0.14%)
MSFT   405.73 (-0.44%)
META   483.21 (+0.31%)
GOOGL   137.83 (+0.19%)
AMZN   174.20 (-0.30%)
TSLA   201.91 (+1.26%)
NVDA   791.66 (+0.09%)
NIO   5.80 (+2.65%)
AMD   177.87 (+1.06%)
BABA   77.65 (+1.49%)
T   16.61 (+0.06%)
F   12.06 (+0.92%)
MU   91.65 (+2.45%)
CGC   3.57 (+2.88%)
GE   153.59 (-0.76%)
DIS   108.49 (+0.75%)
AMC   4.68 (+5.17%)
PFE   26.97 (-0.77%)
PYPL   59.96 (+1.06%)
XOM   104.14 (-0.11%)
CVE:HTL

Hamilton Thorne (HTL) Stock Price, News & Analysis

C$1.45
+0.06 (+4.32%)
(As of 09/6/2023)
Today's Range
C$1.42
C$1.45
50-Day Range
C$1.45
C$1.45
52-Week Range
C$1.25
C$1.73
Volume
25,700 shs
Average Volume
35,118 shs
Market Capitalization
C$212.89 million
P/E Ratio
48.33
Dividend Yield
N/A
Price Target
C$2.40

Hamilton Thorne MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
65.5% Upside
C$2.40 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.37mentions of Hamilton Thorne in the last 14 days
Based on 9 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.92 out of 5 stars


HTL stock logo

About Hamilton Thorne Stock (CVE:HTL)

Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. It offers precision laser systems, imaging systems, and other equipment and consumables for the ART and developmental biology research markets. The company also provides test laboratory and endotoxin testing services, as well as sperm assays, including Sperm Motility Index and Sperm Penetration; and fresh and cryopreserved mouse embryos supply, and technician training and proficiency testing services. In addition, it manufactures and distributes products for reproductive medicine, including clinical and laboratory equipment and disposables, as well as complete installations of ART clinics; and bench top incubators, programmable freezers, loggers, alarms, cryo storage, and software systems and sensors for the safe preservation of medical and biological specimens used in ART and cell biology applications. Further, the company offers Cell-Tek Microscope Chamber, a product for controlling temperature, air flow, humidification, and air quality; laminar flow workstations, incubators, and related products; and artificial intelligence enabled CASA software, consumables, and image analysis systems for the ART and laboratory markets, as well as acts as a value-added reseller of a range of capital equipment and consumables. It sells its products and services through a direct sales force in the United States, Germany, France, Australia, Denmark, Spain, and the United Kingdom, as well as through distributors to fertility clinics, hospitals, pharmaceutical companies, biotechnology companies, educational institutions, and other commercial and academic research establishments in approximately 75 countries. The company is headquartered in Beverly, Massachusetts.

HTL Stock Price History

HTL Stock News Headlines

Energy Storage Trend Ignites Frenzy Over Vanadium Supply
As the world shifts to renewables such as wind and solar, how will we store all this energy? Vanadium batteries are the breakthrough that some experts predict will be the future of grid-scale energy storage. The problem is, only 5% of vanadium is mined in the U.S. - and China and Russia have a stranglehold on our supply.
Energy Storage Trend Ignites Frenzy Over Vanadium Supply
As the world shifts to renewables such as wind and solar, how will we store all this energy? Vanadium batteries are the breakthrough that some experts predict will be the future of grid-scale energy storage. The problem is, only 5% of vanadium is mined in the U.S. - and China and Russia have a stranglehold on our supply.
Why Ferrari makes sense for Hamilton
See More Headlines
Receive HTL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hamilton Thorne and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
C$2.40
High Stock Price Target
C$2.75
Low Stock Price Target
C$2.20
Potential Upside/Downside
+65.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
C$1.43 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$63.02 million
Cash Flow
C$0.10 per share
Book Value
C$0.40 per share

Miscellaneous

Free Float
N/A
Market Cap
C$212.89 million
Optionable
Not Optionable
Beta
0.54
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Mr. David B. Wolf
    Chair, Pres & CEO
  • Mr. Francesco Fragasso CPA
    Chief Financial Officer
  • Mr. Brett M. Fulton
    Sr. VP & GM
  • Mr. Thomas Kenny
    Sr. VP Global Operations & Sustaining Engineering and Management Rep
  • Ms. Kimberly Marolda
    Director of HR
  • Mr. Eric V. Dorman
    Pres of Embryotech Laboratories Inc
  • Dr. Fabian Sell
    Chief Exec. Officer of Gynemed
  • Joel Lopez
    Pres of Embryotech Laboratories
  • Mr. Dan Ryan
    Fin. Controller














HTL Stock Analysis - Frequently Asked Questions

Should I buy or sell Hamilton Thorne stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Hamilton Thorne in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" HTL shares.
View HTL analyst ratings
or view top-rated stocks.

What is Hamilton Thorne's stock price target for 2024?

3 analysts have issued 1 year target prices for Hamilton Thorne's shares. Their HTL share price targets range from C$2.20 to C$2.75. On average, they anticipate the company's stock price to reach C$2.40 in the next twelve months. This suggests a possible upside of 65.5% from the stock's current price.
View analysts price targets for HTL
or view top-rated stocks among Wall Street analysts.

How have HTL shares performed in 2024?

Hamilton Thorne's stock was trading at C$1.45 at the beginning of the year. Since then, HTL stock has increased by 0.0% and is now trading at C$1.45.
View the best growth stocks for 2024 here
.

What other stocks do shareholders of Hamilton Thorne own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Hamilton Thorne investors own include Trican Well Service (TCW), mdf commerce (MDF), Micron Technology (MU), LHC Group (LHCG), Mainstreet Equity (MEQ), Materialise (MTLS), AltaGas (ALA), Bank of America (BAC) and British American Tobacco (BATS).

How do I buy shares of Hamilton Thorne?

Shares of HTL stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:HTL) was last updated on 2/27/2024 by MarketBeat.com Staff